Cargando…
Host-Directed Therapeutic Strategies for Tuberculosis
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of morbidity and mortality in humans worldwide. Currently, the standard treatment for TB involves multiple antibiotics administered for at least 6 months. Although multiple antibiotics therapy is necessary to prev...
Autores principales: | Kolloli, Afsal, Subbian, Selvakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651239/ https://www.ncbi.nlm.nih.gov/pubmed/29094039 http://dx.doi.org/10.3389/fmed.2017.00171 |
Ejemplares similares
-
Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
por: Kumar, Ranjeet, et al.
Publicado: (2020) -
Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary Mycobacterium tuberculosis Infection
por: Kolloli, Afsal, et al.
Publicado: (2019) -
Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology
por: Kolloli, Afsal, et al.
Publicado: (2021) -
Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration
por: Kumar, Ranjeet, et al.
Publicado: (2021) -
Imaging Architecture of Granulomas Induced by Mycobacterium tuberculosis Infections with Single-Molecule FISH
por: Kumar, Ranjeet, et al.
Publicado: (2023)